Weight-loss jabs ‘important for economy so people get back into work’, says PM - Sir Keir Starmer said anti-obesity ...

GLP-1 agonists work by suppressing patients’ appetites and have been approved to treat obesity and type 2 diabetes in the ...

Nearly a quarter-of-a-million people are expected to receive the Mounjaro jab over the next three years. NHS officials have ...

Patients will first be eligible to receive the drug if they have a BMI over 40 and at least three of specified weight-related ...

A new study found that obese teens prescribed with weight loss drugs are less likely to have suicidal thoughts.

A study by Health Innovation Manchester and Lilly will examine the “real-world effectiveness” of anti-obesity treatment Mounjaro, also known as tirzepatide, on weight loss, diabetes prevention, the ...

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...

Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.

As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Dr. Brett Osborn and Dr. Sue Decotiis warn of potential risks.

Wylie said: "Ozempic (semaglutide) is a medication licensed for the management of type 2 diabetes. While it has shown ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.